Previous Article | Next Article 
Journal of Clinical Microbiology, January 1999, p. 157-160, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Detection of Penicillin Susceptibility in Streptococcus
pneumoniae by pbp2b PCR-Restriction Fragment
Length Polymorphism Analysis
A. M.
O'Neill,
S.
H.
Gillespie,* and
G.
C.
Whiting
Department of Medical Microbiology, Royal
Free Hospital School of Medicine, London NW3 2PF, United Kingdom
Received 18 June 1998/Returned for modification 4 August
1998/Accepted 29 September 1998
 |
ABSTRACT |
A PCR-restriction fragment length polymorphism strategy directed
against the pbp2b gene was evaluated for identification of penicillin susceptibility. A total of 106 United Kingdom (U.K.), 30 Danish, and 11 Papua New Guinean strains were tested. Of the U.K.
strains, all the susceptible and all but one of the resistant isolates
were correctly assigned. By using conventional definitions of "not
resistant" and "not susceptible," the sensitivities were 97.5 and
94.4%, the specificities were 100 and 98.9%, the positive predictive
values were 100 and 94.4%, and the negative predictive values were
93.1 and 98.9%, respectively. This technique may allow susceptible
(MIC, <0.1 mg/liter) and resistant (MIC, >1 mg/liter) isolates to be
distinguished in a single PCR.
 |
INTRODUCTION |
Streptococcus
pneumoniae remains an important human pathogen associated
with significant morbidity and mortality. The case fatality rates are 5 to 7% for hospitalized community-acquired pneumonia, 20% for
bacteremia, and up to 40% for meningitis (1). S. pneumoniae was once universally susceptible to penicillin, but
since being first identified as an important clinical problem in the
late 1970s resistance has risen inexorably throughout the world
(2). Treatment in response to a diagnosis of relative penicillin resistance requires either an increase in dosage, as in the
case of pneumonia, or a change to a third-generation cephalosporin, as
in the case of meningitis. It is important that the laboratory rapidly
identifies penicillin resistance.
Conventional culture-based susceptibility testing can be
difficult to perform, although national and international
standards have now been published (9, 10). Several DNA
amplification-based techniques have been described that use a
combination of pbp2B and lytA PCRs as
targets (11). Alternatively, a combination of a
pbp1a PCR directed towards a resistant genotype and PCRs directed towards susceptible genotypes of pbp2b and
-2x has been used (7). A restriction
fragment length polymorphism (RFLP) strategy has also been investigated
and has been shown to be valuable in molecular epidemiological studies
at the national and hospital levels (5). In this paper we
present data which show that this technique can be modified to reliably
differentiate susceptible and resistant organisms and can be used to
complement PCR diagnosis (4).
 |
MATERIALS AND METHODS |
Bacterial strains.
A total of 106 S. pneumoniae
isolates were obtained from a community-wide study from the United
Kingdom (U.K.). In addition, 11 isolates from Papua New Guinea and 30 isolates from Denmark were also studied. The U.K. isolates were
obtained from blood cultures (70), sputum (23), bronchoalveolar lavage
(1), lung abscess (1), pleural fluid (1), ear swabs (4), wound swabs
(2), throat swab (1), nasal swab (1), cerebrospinal fluid (1), and
joint fluid (1). The age range of the patients from whom the isolates
were obtained was 18 months to 92 years. The serotyping was performed by the Streptococcal Reference Laboratory of the Central Public Health
Laboratory, Colindale, London, United Kingdom. The resistant U.K.
strains had serotypes of 6B, 9, 9V, 19F, 23, and 23F. The resistant
Denmark strain serotypes were 9V, 14, and 23F. The serotypes of the
U.K. intermediately resistant strains were 6B, 8, 15, 15B, 19, 22, 23, and 24. The serotypes of the Denmark intermediately resistant strains
were 12F, 14, 15A, 15C, 19A, 19F, 23F, and 63. The U.K. susceptible
strains showed a total of 27 different serotypes. The serotypes of the
two Denmark susceptible strains were 19A and 6B.
DNA isolation.
S. pneumoniae was cultivated on blood
agar in 5 to 10% carbon dioxide at 37°C overnight. Colonies were
emulsified in 50 µl of sterile distilled water in a microcentrifuge
tube and then incubated at 95°C for 5 min in a PCR machine;
supernatant containing DNA was used for PCRs.
PCRs.
The PCRs were modified from a previously published
protocol (5). The pbp2b gene was amplified with
primers 5' GAT CCT CTA AAT GAT TCT CAG GTG G 3' and 5' CAA TTA GCT TAG
CAA TAG GTG TTG G 3'. The primers were supplied high-pressure liquid
chromatography purified by R & D Systems (Europe) Limited.
The optimal reaction mix included 1 U of Taq polymerase
(Bioline, London, United Kingdom), 10 µl (100 mM) of ammonium sulfate buffer, 3 µl (5 mM) of deoxynucleotide triphosphates (Promega, Southampton, United Kingdom), 3 µl (5 mM) magnesium chloride
(Bioline), 4 µl of primers (0.1 mM), 5 µl of DNA template, and
sterile distilled water to a final volume of 100 µl. This was
overlaid with mineral oil and processed on an Omnigene thermocycler
(Hybaid, London, United Kingdom). The optimal PCR cycling conditions
were as follows: 95°C for 5 min followed by 30 cycles of 94°C for 1 min, 55°C for 2 min, and 72°C for 3 min. The final cycle was run at
72°C for 7 min. A total of 10 µl of the products of the PCR was
analyzed by electrophoresis through a 1.8% agarose-ethidium
bromide-containing gel with pGEM molecular weight standards (Promega)
as markers.
The PCR products were digested with HinfI (Promega). The
digestion mixture consisted of 1 µl of HinfI enzyme (10 U
per µl) in 10 mM Tris-HCl (pH 7.5)-60 mM sodium chloride-7 mM
magnesium chloride-0.1-mg bovine serum albumin per liter in a 50-µl
volume. A total of 20 µl of PCR product was added to 2 µl of buffer
and 1 µl of HinfI enzyme. Digestion proceeded for 16 h at 37°C with the Omnigene thermocycler, and the products were run
on a 1.8% agarose gel as described above.
Determination of MICs.
MICs were determined by an agar
dilution method according to the British Society of Antimicrobial
Chemotherapy guidelines (10). A 6-h culture of test
organisms in brain heart infusion broth was diluted and inoculated with
a multipoint inoculator to give 104 organisms per spot onto
Isosensitest agar containing 5% lysed horse blood and differing
concentrations of penicillin. The concentrations of organisms were
confirmed by using the Miles and Misra technique (7). The
Oxford strain of Staphylococcus aureus (NCTC 6571) was used
as a control. The concentrations of penicillin used ranged from 0.09 to
1.2 mg/liter by increments of 0.1 and then from 1.2 to 2.0 mg/liter by
increments of 0.2. Above and below these levels doubling dilutions were
performed. The MIC was determined as the concentration in last plate
showing growth of less than 10 colonies. Isolates were defined as
susceptible with an MIC of <0.1 mg/liter, intermediately resistant
with an MIC of 0.1 to <1 mg/liter, and resistant with an MIC of >1
mg/liter.
Analysis of RFLP patterns.
RFLP patterns were digitized by
using a Hewlett- Packard Scanjet 4C/T, and the band positions were
analyzed using the Gel Compar program version 4.0 (Applied Maths,
Krotrijk, Belgium). pGEM markers were used as the reference standards.
The band positions were normalized, and dendrograms were calculated by
using the dice coefficient with band settings of minimal profiling of
5%, minimal area of 0.5%, band comparison settings of position
tolerance of 2%, increase 0, and minimal area 0. These conditions were
chosen to give similarities between the markers of >90%.
 |
RESULTS |
For the U.K. isolates a total of 11 different RFLP patterns could
be defined for the pbp2b gene with Gel Compar. These are illustrated in Fig. 1. A total of 77 susceptible organisms produced an identical pattern: pattern A. The 11 intermediately resistant strains (as defined by MIC) exhibited nine
different RFLP patterns: 6 had patterns that were only found in
intermediately resistant strains; 2 had pattern A, found in all
of the susceptible strains; and 2 had patterns I and K, which were
associated with resistant strains. Among the 18 resistant
strains, all but 3 exhibited a similar genotype: pattern K. The three
remaining resistant strains showed patterns H, I, and
. The MICs and
RFLP patterns of the U.K. isolates are illustrated in Fig.
2.
We used pattern A to define PCR susceptibility and an MIC of <0.1
mg/liter to define conventional susceptibility. This is illustrated in
Table 1. With these figures the PCR-RFLP
methodology has a sensitivity of 97.5%, a specificity of 100%, a
positive predictive value of 94.4%, and a negative predictive value of 98.9%. This is summarized in Table 1.
To determine the ability of this technique to detect resistance, we
defined PCR resistance as pattern K, H, or
and conventional resistance as an MIC of >1.0 mg/liter. Defined thus, the PCR-RFLP methodology has a sensitivity of 94.4%, a specificity of 98.9%, a
positive predictive value of 94.4%, and a negative predictive value of
98.9%. This is summarized in Table 1.
Among the 30 isolates from Denmark five different RFLP patterns were
observed. Only two of the organisms were susceptible, having MICs of
0.09 mg/liter, and both of these expressed pattern A. There were 14 resistant strains, 11 of which exhibited pattern K and 3 of which
exhibited pattern H; both patterns had previously been associated with
resistant strains among U.K. isolates. Among the 14 intermediately
resistant strains, 8 showed pattern A (the susceptible pattern), a
single strain demonstrated the resistant pattern K, and 2 had patterns
that were previously associated with intermediate resistance in the
U.K. isolates. The 11 isolates from Papua New Guinea were either
susceptible or intermediately resistant. All six susceptible strains
exhibited pattern A. A total of four of five intermediately resistant
strains had pattern A, and one had a pattern previously associated with
intermediate resistance.
 |
DISCUSSION |
Several different approaches have been adopted for the molecular
diagnosis of penicillin resistance. Ubukata et al. used a combination
of PCRs that were targeted on lytA, a 240-bp fragment from
the pbp of susceptible strains, and two different penicillin mutant pbp2b gene sequences (11). Another group
used primers based on susceptible pbp2x genes and a
resistant pbp1a gene (6). By using the data
provided in these publications it is possible to calculate the
performance parameters for these tests. These data are found in Table
2 and show that all of these approaches are excellent at verifying fully susceptible strains. This is as
expected because of the genetic conservation of penicillin-susceptible genes (2). On the other hand, both fully PCR-based systems had difficulty detecting resistant isolates. All of the resistant isolates identified were truly resistant, but those strains with a
sequence not encompassed by the primers were not amplified and thus
gave false-negative results. This problem is overcome by our method as
the primer design is based on a sequence which is conserved in
susceptible and resistant strains. Thus, genes from susceptible and
resistant isolates are amplified. It is then possible to determine
resistance because the pattern of endonuclease digestion differs enough
between different resistant alleles. This was aided by a limited number
of resistant RFLPs, all but three of which were pattern K although the
isolates belonged to four different serogroups.
The PCR-RFLP method has the best sensitivity and specificity of the
molecular methods, but these data may be an underestimate of the
sensitivity. Pattern I, found in a single intermediately resistant and
a single resistant strain, was defined as intermediate resistance, and
therefore the resistant strain was considered a false negative. It may
be that this is a resistant pattern, and thus, study of more strains
from a wide geographical area should show whether this is a resistant
or an intermediately resistant pattern, thereby possibly improving the
specificity of the method. This study shows that there is sufficient
diversity between susceptible and resistant isolates for these to
be clearly distinguished.
One of the major difficulties with all of the previously reported
molecularly based susceptibility tests concerns the identification of
resistance in strains from overseas (6). Our RFLP
methodology appeared not to have this difficulty as we were able to
correctly identify both susceptible strains and 14 resistant strains
from Denmark. This needs to be tested further by examining strains from many more countries. We did have difficulty in correctly identifying intermediately resistant strains as 8 of the 14 intermediately resistant strains were identified as susceptible and 1 was identified as resistant. Similarly, all susceptible strains from
Papua New Guinea were correctly identified but four of five
intermediately resistant strains were identified as susceptible. The
recently reported technique of du Plessis et al., for application to
cultures and cerebrospinal fluid, uses a seminested technique with
species-specific conserved primers and four resistance primers for
pbp2b. This technique was evaluated on 35 isolates,
identifying all of the resistant isolates correctly (3).
All previously reported techniques require multiple PCR amplifications.
Our method uses a single reaction, which has previously been shown to
be species specific (5). Thus, incorrectly identified streptococcal species will not amplify, alerting the scientist to the
need to check the identification. All of the molecular methods have
difficulty in identifying strains that are intermediately resistant.
Although this technique used a 16-h incubation it could be accelerated
by performing the digestion with a higher concentration of
HinfI. This change would provide a method which would be
more rapid than the conventional agar-based approach. As more isolates are examined their RFLP patterns can be added to our database. It is
hoped that this will allow more accurate detection of intermediately resistant isolates in the future, thus providing a molecularly based
method of susceptibility testing in a single PCR.
 |
ACKNOWLEDGMENTS |
This work was supported in part by the Royal Free Hospital
Special Trustees and the Wellcome Trust.
We are grateful to Deborah Lehman and Jørgen Henrichsen for the supply
of strains and to Therese Donnelly for secretarial support. We
gratefully acknowledge the help of the Streptococcal Reference
Laboratory of the Central Public Health Laboratory, Colindale, London,
United Kingdom, for serotyping.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology, Royal Free Hospital School of Medicine, Rowland Hill St., London NW3 2PF, United Kingdom. Phone: 44-(0)171-794-0500. Fax: 44-(0)171-794-0433. E-mail: stepheng{at}rfhsm.ac.uk.
 |
REFERENCES |
| 1.
|
Austrian, A.
1997.
The enduring pneumococcus: unfinished business and opportunities for the future.
Microb. Drug Resist.
3:111-115.
[Medline] |
| 2.
|
Dowson, C. G.,
T. J. Coffey, and B. G. Spratt.
1994.
Origin and molecular epidemiology of penicillin binding protein mediated resistance to -lactam antibiotics.
Trends Microbiol.
2:361-366[Medline].
|
| 3.
|
du Plessis, M.,
A. M. Smith, and K. P. Klugman.
1998.
Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy.
J. Clin. Microbiol.
36:453-457[Abstract/Free Full Text].
|
| 4.
|
Gillespie, S. H.,
C. Ullman,
M. D. Smith, and V. Emery.
1994.
Detection of Streptococcus pneumoniae in sputum samples by PCR.
J. Clin. Microbiol.
32:1308-1311[Abstract/Free Full Text].
|
| 5.
|
Gillespie, S. H.,
T. D. McHugh,
J. E. Hughes,
A. Dickens,
M. S. Kyi, and M. Kelsey.
1997.
An outbreak of penicillin resistant Streptococcus pneumoniae investigated by a polymerase chain reaction based genotyping method.
J. Clin. Pathol.
50:847-851[Abstract/Free Full Text].
|
| 6.
|
Jalal, H.,
S. Organji,
J. Reynolds,
D. Bennett,
E. O'Mason, and M. R. Millar.
1997.
Determination of penicillin susceptibility of Streptococcus pneumoniae using the polymerase chain reaction.
J. Clin. Pathol. Mol. Pathol.
50:45-50.
[Abstract/Free Full Text] |
| 7.
|
Miles, A. A., and S. S. Misra.
1938.
The estimation of the bactericidal power of blood.
J. Hyg. Camb.
38:732-749.
|
| 8.
|
Munoz, R.,
J. M. Musser,
M. Crain,
D. E. Briles,
A. Marton,
A. J. Parkinson,
U. Sorenson, and A. Tomasz.
1992.
Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing and multilocus enzyme electrophoresis.
Clin. Infect. Dis.
15:112-118[Medline].
|
| 9.
|
National Committee for Clinical Laboratory Standards.
1993.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards M7-A3, 3rd ed.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 10.
| Report of a Working Party. 1991. A guide to
sensitivity testing. J. Antimicrob. Chemother. 27 (Suppl.
D):1-50.
|
| 11.
|
Ubukata, K.,
Y. Asahi,
A. Yamane, and M. Konno.
1996.
Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR.
J. Clin. Microbiol.
34:592-596[Abstract].
|
Journal of Clinical Microbiology, January 1999, p. 157-160, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Harris, K. A., Turner, P., Green, E. A., Hartley, J. C.
(2008). Duplex Real-Time PCR Assay for Detection of Streptococcus pneumoniae in Clinical Samples and Determination of Penicillin Susceptibility. J. Clin. Microbiol.
46: 2751-2758
[Abstract]
[Full Text]
-
Suzuki, N., Yuyama, M., Maeda, S., Ogawa, H., Mashiko, K., Kiyoura, Y.
(2006). Genotypic identification of presumptive Streptococcus pneumoniae by PCR using four genes highly specific for S. pneumoniae. J Med Microbiol
55: 709-714
[Abstract]
[Full Text]
-
Suzuki, N., Seki, M., Nakano, Y., Kiyoura, Y., Maeno, M., Yamashita, Y.
(2005). Discrimination of Streptococcus pneumoniae from Viridans Group Streptococci by Genomic Subtractive Hybridization. J. Clin. Microbiol.
43: 4528-4534
[Abstract]
[Full Text]
-
Saglani, S, Harris, K A, Wallis, C, Hartley, J C
(2005). Empyema: the use of broad range 16S rDNA PCR for pathogen detection. Arch. Dis. Child.
90: 70-73
[Abstract]
[Full Text]
-
Harris, K. A., Hartley, J. C.
(2003). Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. J Med Microbiol
52: 685-691
[Abstract]
[Full Text]
-
Fluit, A. C., Visser, M. R., Schmitz, F.-J.
(2001). Molecular Detection of Antimicrobial Resistance. Clin. Microbiol. Rev.
14: 836-871
[Abstract]
[Full Text]
-
McAvin, J. C., Reilly, P. A., Roudabush, R. M., Barnes, W. J., Salmen, A., Jackson, G. W., Beninga, K. K., Astorga, A., McCleskey, F. K., Huff, W. B., Niemeyer, D., Lohman, K. L.
(2001). Sensitive and Specific Method for Rapid Identification of Streptococcus pneumoniae Using Real-Time Fluorescence PCR. J. Clin. Microbiol.
39: 3446-3451
[Abstract]
[Full Text]